BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway
BRCA mutation testing in patients with ovarian cancer has become more widely incorporated into clinical practice over time, owing to its importance for prognosis and for risk-reducing measures in the families of patients carrying mutation, and possibly contributes to a decrease in ovarian cancer incidence.
Authors
- Merete Bjørnslett (ORCID: https://orcid.org/0000-0002-1788-2869)
- Teressa Paulsen (ORCID: https://orcid.org/0000-0002-3559-2574)
- Vibeke W Rognlien
- Anne Dørum (ORCID: https://orcid.org/0000-0002-6274-2398)
- Tor Åge Myklebust (ORCID: https://orcid.org/0000-0003-4645-1635)
- Alda Birgisdóttir
Institutions
- Oslo University Hospital (NO)
- Norwegian Cancer Society (NO)
- Cancer Registry of Norway (NO)
Publication Details
- Journal
- International Journal of Gynecological Cancer
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1016/j.ijgc.2024.100029
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00